Influence of tumor location on breast cancer prognosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Influence of tumor location on breast cancer prognosis. / Kroman, Niels; Wohlfahrt, Jan; Mouridsen, Henning T.; Melbye, Mads.

I: International Journal of Cancer, Bind 105, Nr. 4, 01.07.2003, s. 542-545.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kroman, N, Wohlfahrt, J, Mouridsen, HT & Melbye, M 2003, 'Influence of tumor location on breast cancer prognosis', International Journal of Cancer, bind 105, nr. 4, s. 542-545. https://doi.org/10.1002/ijc.11116

APA

Kroman, N., Wohlfahrt, J., Mouridsen, H. T., & Melbye, M. (2003). Influence of tumor location on breast cancer prognosis. International Journal of Cancer, 105(4), 542-545. https://doi.org/10.1002/ijc.11116

Vancouver

Kroman N, Wohlfahrt J, Mouridsen HT, Melbye M. Influence of tumor location on breast cancer prognosis. International Journal of Cancer. 2003 jul. 1;105(4):542-545. https://doi.org/10.1002/ijc.11116

Author

Kroman, Niels ; Wohlfahrt, Jan ; Mouridsen, Henning T. ; Melbye, Mads. / Influence of tumor location on breast cancer prognosis. I: International Journal of Cancer. 2003 ; Bind 105, Nr. 4. s. 542-545.

Bibtex

@article{369fb12c73604cf1a07d878719b08335,
title = "Influence of tumor location on breast cancer prognosis",
abstract = "Our objective was to investigate the influence of primary tumor location on breast cancer prognosis. We used a population-based registry since 1977 that has collected detailed information regarding clinical and histopathological presentation, postoperative therapy and follow-up status on Danish women with breast cancer. Nodal status and relative risk of dying was estimated according to primary tumor localization in the breast. Overall, 35,319 patients with primary breast cancer were included in the study. After adjustment for prognostic factors, the risk of dying increased significantly (up to 21%) with increasing distance of tumor location from the axilla. This trend was seen both among women with and without spread to the axillary lymph nodes. In conclusion, survival is significantly better for women with a tumor in the upper lateral quadrant than tumors located elsewhere in the breast. Our finding of a similar trend according to distance from the axilla among women with positive axillary lymph nodes who all are allocated to systemic therapy suggests that a better lymph node staging procedure alone is unlikely to eliminate these survival differences. Other reasons for the observed differences should be sought to help improve survival for women with breast cancer.",
keywords = "Breast cancer, Lymph nodes, Population-based, Prognosis, Staging procedures, Tumor location",
author = "Niels Kroman and Jan Wohlfahrt and Mouridsen, {Henning T.} and Mads Melbye",
year = "2003",
month = jul,
day = "1",
doi = "10.1002/ijc.11116",
language = "English",
volume = "105",
pages = "542--545",
journal = "Acta - Unio Internationalis Contra Cancrum",
issn = "0898-6924",
publisher = "JohnWiley & Sons, Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Influence of tumor location on breast cancer prognosis

AU - Kroman, Niels

AU - Wohlfahrt, Jan

AU - Mouridsen, Henning T.

AU - Melbye, Mads

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Our objective was to investigate the influence of primary tumor location on breast cancer prognosis. We used a population-based registry since 1977 that has collected detailed information regarding clinical and histopathological presentation, postoperative therapy and follow-up status on Danish women with breast cancer. Nodal status and relative risk of dying was estimated according to primary tumor localization in the breast. Overall, 35,319 patients with primary breast cancer were included in the study. After adjustment for prognostic factors, the risk of dying increased significantly (up to 21%) with increasing distance of tumor location from the axilla. This trend was seen both among women with and without spread to the axillary lymph nodes. In conclusion, survival is significantly better for women with a tumor in the upper lateral quadrant than tumors located elsewhere in the breast. Our finding of a similar trend according to distance from the axilla among women with positive axillary lymph nodes who all are allocated to systemic therapy suggests that a better lymph node staging procedure alone is unlikely to eliminate these survival differences. Other reasons for the observed differences should be sought to help improve survival for women with breast cancer.

AB - Our objective was to investigate the influence of primary tumor location on breast cancer prognosis. We used a population-based registry since 1977 that has collected detailed information regarding clinical and histopathological presentation, postoperative therapy and follow-up status on Danish women with breast cancer. Nodal status and relative risk of dying was estimated according to primary tumor localization in the breast. Overall, 35,319 patients with primary breast cancer were included in the study. After adjustment for prognostic factors, the risk of dying increased significantly (up to 21%) with increasing distance of tumor location from the axilla. This trend was seen both among women with and without spread to the axillary lymph nodes. In conclusion, survival is significantly better for women with a tumor in the upper lateral quadrant than tumors located elsewhere in the breast. Our finding of a similar trend according to distance from the axilla among women with positive axillary lymph nodes who all are allocated to systemic therapy suggests that a better lymph node staging procedure alone is unlikely to eliminate these survival differences. Other reasons for the observed differences should be sought to help improve survival for women with breast cancer.

KW - Breast cancer

KW - Lymph nodes

KW - Population-based

KW - Prognosis

KW - Staging procedures

KW - Tumor location

UR - http://www.scopus.com/inward/record.url?scp=0038273966&partnerID=8YFLogxK

U2 - 10.1002/ijc.11116

DO - 10.1002/ijc.11116

M3 - Journal article

C2 - 12712447

AN - SCOPUS:0038273966

VL - 105

SP - 542

EP - 545

JO - Acta - Unio Internationalis Contra Cancrum

JF - Acta - Unio Internationalis Contra Cancrum

SN - 0898-6924

IS - 4

ER -

ID: 259460453